CD300f epitopes are specific targets for acute myeloid leukemia with monocytic differentiation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CD300f epitopes are specific targets for acute myeloid leukemia with monocytic differentiation

Published:2019-08-20 Issue:10 Volume:13 Page:2107-2120
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:Mol Oncol

Author:

Abadir Edward¹²,Gasiorowski Robin E.¹²³,Lai Kaitao²⁴⁵,Kupresanin Fiona¹,Romano Adelina¹,Silveira Pablo A.¹²,Lo Tsun‐Ho¹²,Fromm Phillip D.¹²,Kennerson Marina L.²⁵⁶,Iland Harry J.²⁷,Ho P. Joy²⁷,Hogarth P. Mark⁸,Bradstock Kenneth⁹,Hart Derek N.J.¹²⁷,Clark Georgina J.¹²^ORCID

Affiliation:

1. Dendritic Cell Research ANZAC Research Institute Sydney Australia

2. Sydney Medical School University of Sydney Australia

3. Department of Haematology Concord Repatriation General Hospital Sydney Australia

4. ANZAC Research Institute Sydney Australia

5. Northcott Neuroscience Laboratory ANZAC Research Institute Sydney Australia

6. Molecular Medicine Laboratory Concord Repatriation General Hospital Sydney Australia

7. Institute of Haematology Royal Prince Alfred Hospital Sydney Australia

8. Immune Therapies Burnet Institute Melbourne Australia

9. Department of Haematology Westmead Hospital Sydney Australia

Funder

Cancer Institute NSW

National Health and Medical Research Council

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/1878-0261.12549

Reference30 articles.

1. A Genome-Wide Aberrant RNA Splicing in Patients with Acute Myeloid Leukemia Identifies Novel Potential Disease Markers and Therapeutic Targets

2. IREM-1 is a novel inhibitory receptor expressed by myeloid cells

3. The IREM-1 (CD300f) Inhibitory Receptor Associates with the p85α Subunit of Phosphoinositide 3-Kinase

4. Gemtuzumab ozogamicin for the treatment of acute promyelocytic leukemia: mechanisms of action and resistance, safety and efficacy

5. The CD300 family of molecules are evolutionarily significant regulators of leukocyte functions

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CD300f signalling induces inhibitory human monocytes/macrophages;Cellular Immunology;2023-08

2. TP53 and RB1 alterations characterize poor prognostic subgroups in pediatric acute myeloid leukemia;Genes, Chromosomes and Cancer;2023-04-27

3. The interaction of CD300lf and ceramide reduces the development of periodontitis by inhibiting osteoclast differentiation;Journal of Clinical Periodontology;2022-10-25

4. Pan‐cancer analysis identifies CD300 molecules as potential immune regulators and promising therapeutic targets in acute myeloid leukemia;Cancer Medicine;2022-05-31

5. CD300lf Conditional Knockout Mouse Reveals Strain-Specific Cellular Tropism of Murine Norovirus;Journal of Virology;2021-01-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3